<DOC>
	<DOCNO>NCT01344655</DOCNO>
	<brief_summary>This crossover Study investigate effect Formoterol versus Salmeterol small airway physiological parameter COPD patient .</brief_summary>
	<brief_title>Study Investigate Effect Formoterol v Salmeterol Small Airways Physiological Parameters COPD Patients</brief_title>
	<detailed_description>A Single-centre , Double-blind , Double-dummy , Randomised , Crossover Study investigate effect Formoterol HFA-pMDI versus Salmeterol HFA-pMDI small airway physiological parameter COPD patient .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Patients clinical diagnosis COPD Post bronchodilator FEV1 30 % 80 % predict value screen Postbronchodilator FEV1/FVC &lt; 0.7 Positive FEV1 reversibility test : FEV1 change great 200 mL 12 % History another medical condition contraindicate participation study Clinical evidence heart failure</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>